drugset / Trial / NCT02479308
A Study to Evaluate the Effect of ALKS 5461 on QT Intervals in Healthy Volunteers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will evaluate the effects of ALKS 5461 on QT intervals in healthy volunteers as well as evaluate the safety and tolerability of ALKS 5461.
Timeline
- Start
- 2015-06
- Primary completion
- 2015-10
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ALKS 5461 | Unknown | — | Other |
| Comparator | Moxifloxacin | Small molecule | — | Oral |
Indications
No indication recorded.